Outcome and Improvement of Different Treatment in Arteriosclerosis Obliterans | MicrobiomeTrials← Back to trialsNCT06485622
Outcome and Improvement of Different Treatment in Arteriosclerosis Obliterans
RecruitingOBSERVATIONAL
Trial Details
Start: 2024-07-01Est. Completion: 2027-07
Enrollment target: 400 participants Locations- The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China
Other microbiome trials you might be interested in
Critical Limb IschemiaBuerger's Disease
The goal of this observational, practice-based feasibility study is to observe the efficacy and safety of intramuscular …
Kuala Lumpur, MalaysiaEst. completion Oct 2027
Panvascular DiseasesCardiovascular Diseases
This study aims to establish a standardized cohort for panvascular diseases, encompassing biological materials such as D…
Harbin, ChinaEst. completion Dec 31, 2030